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OBJECTIVES: (1) To  assess whether neuroticism, state anxiety, and body vigilance are higher in patients with persistent postural-
perceptual dizziness (PPPD) compared to a recovered vestibular patient group and a non-dizzy patient group; (2) To gather pilot
data on illness perceptions of patients with PPPD. MATERIALS AND METHODS: 15 cases with PPPD and two control groups: (1)
recovered vestibular patients (n=12) and (2) non-dizzy patients (no previous vestibular insult, n=12). Main outcome measures:
Scores from the Big Five Inventory (BFI) of personality traits, Generalised Anxiety Disorder – 7 (GAD-7) scale, Body Vigilance Scale
(BVS), Dizziness Handicap Inventory (DHI), modified Vertigo Symptom Scale (VSS) and Brief Illness Perception Questionnaire (BIPQ).
RESULTS: Compared to non-dizzy patients, PPPD cases had higher neuroticism (p=0.02), higher introversion (p=0.008), lower
conscientiousness (p=0.03) and higher anxiety (p=0.02). There were no differences between PPPD cases and recovered vestibular
patients in BFI and GAD-7. PPPD cases had higher body vigilance to dizziness than both control groups and their illness perceptions
indicated higher levels of threat than recovered vestibular patients. CONCLUSION: PPPD patients showed statistically significant
differences to non-dizzy patients, but not recovered vestibular controls in areas such as neuroticism and anxiety. Body vigilance
was increased in PPPD patients when compared with both recovered vestibular and non-dizzy patient groups. PPPD patients also
exhibited elements of negative illness perception suggesting that this may be the key element driving the development of PPPD.
Large scale studies focusing on this area in the early stages following vestibular insult are needed.
  
 Contribution to the field
The risk factors that make people prone to persistent postural-perceptual are still largely unknown but have been hypothesised to
be underlying factors such as neuroticism, anxiety and increased body vigilance. This manuscript examines these factors in detail
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OBJECTIVES: (1) To  assess whether neuroticism, state anxiety, and body vigilance are higher in 24 
patients with persistent postural-perceptual dizziness (PPPD) compared to a recovered vestibular 25 
patient group and a non-dizzy patient group; (2) To gather pilot data on illness perceptions of patients 26 
with PPPD. MATERIALS AND METHODS: 15 cases with PPPD and two control groups: (1) recovered 27 
vestibular patients (n=12) and (2) non-dizzy patients (no previous vestibular insult, n=12). Main outcome 28 
measures: Scores from the Big Five Inventory (BFI) of personality traits, Generalised Anxiety Disorder 29 
– 7 (GAD-7) scale, Body Vigilance Scale (BVS), Dizziness Handicap Inventory (DHI), modified Vertigo 30 
Symptom Scale (VSS) and Brief Illness Perception Questionnaire (BIPQ). RESULTS: Compared to 31 
non-dizzy patients, PPPD cases had higher neuroticism (p=0.02), higher introversion (p=0.008), lower 32 
conscientiousness (p=0.03) and higher anxiety (p=0.02). There were no differences between PPPD 33 
cases and recovered vestibular patients in BFI and GAD-7. PPPD cases had higher body vigilance to 34 
dizziness than both control groups and their illness perceptions indicated higher levels of threat than 35 
recovered vestibular patients. CONCLUSION: PPPD patients showed statistically significant 36 
differences to non-dizzy patients, but not recovered vestibular controls in areas such as neuroticism 37 
and anxiety. Body vigilance was increased in PPPD patients when compared with both recovered 38 
vestibular and non-dizzy patient groups. PPPD patients also exhibited elements of negative illness 39 
perception suggesting that this may be the key element driving the development of PPPD. Large scale 40 
studies focusing on this area in the early stages following vestibular insult are needed.  41 
 42 
Introduction 43 
The diagnosis persistent postural-perceptual dizziness (PPPD) entered the 11th edition of the World 44 
Health Organization’s International Classification of Diseases (ICD-11 beta draft) in 2015 following a 45 
consensus document on its diagnostic criteria created by Bárány Society for the International 46 
Classification of Vestibular Disorders (ICVD) and the criteria for its dignosis are outlined in Table 11-3. 47 
 48 
PPPD is a relatively new diagnosis and to date it is still not clear what predisposes some people to it 49 
following known triggers such as acute, episodic, or chronic vestibular syndromes, other neurological 50 
or medical illnesses, or psychological distress. Several authors have shown that acute anxiety and body 51 
vigilance predicted chronic dizziness after acute vestibulopathies4-8. A prospective study found that 52 
psychological distress predicted severity of dizziness-related handicap among patients with various 53 
vestibular disorders in the 12 months following tertiary consultation.9 Neuroticism, the personality trait 54 
tendency to experience negative emotions or psychological distress in response to life events, has also 55 
been identified as a possible predisposing risk factor in both PPPD and chronic subjective dizziness 56 
(CSD), one of PPPD’s precursors10-12. In addition patients’ appraisals and perceptions of their illness 57 
have been shown to influence outcomes in a range of other medical conditions including vestibular 58 
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disorders13,14. (Figure 1). Apart one study of neuroticism, however,10 these investigations were 59 
conducted prior to publication of the ICD-11 and ICVD definitions of PPPD or included patients with 60 
combinations of structural, metabolic, psychiatric, and  functional causes of vestibular symptoms.  As 61 
such, they offer data to formulate hypotheses about roles that psychological variables and illness 62 
perceptions may play in the developement of PPPD.  Confirmation or refutation of those hypotheses 63 
requires investigations that include patients explicitly diagnosed with PPPD and carefully selected 64 
comparison groups.  In addition, it is yet to be deterimined if any of these factors are associated strongly 65 
and uniquely enough with the onset of PPPD to be useful for early detection of the disorder.   66 
 67 
As a first step in validating hypotheses about the relationship of psychological variables specifically to 68 
PPPD and with the intent of designing a prospective trial to predict patients at risk for developing this 69 
disorder, the primary aim of this current study was to gather pilot data to test the hypothesis that the 70 
frequency of anxiety-related variables is higher in patients who meet ICVD criteria for PPPD compared 71 
to those who suffered acute vestibulopathies but did not develop PPPD and patients without a history 72 
of dizziness who were receiving treatment for other medical conditions. The second aim was to gather 73 
pilot data on illness perceptions in patients with PPPD.  Findings of an increased prevalence or severity 74 
of anxiety-related variables or adverse illness perceptions would provide an impetus for conducting 75 
fully-powered, prospective studies with the aim of identifying a risk profile for PPPD that could guide 76 
early interventions for patients susceptible to developing this burdensome chronic dizziness condition.  77 
 78 
Methodology 79 
The study was conducted as a case-control observational study (www.clinicaltrials.gov, reference 80 
NCTO3930485, with ethical approval from South West – Cornwall & Plymouth Research Ethics 81 
Committee). All participants (both cases and controls) were aged ³18 years old and were able to provide 82 
informed consent. Any participants who were <18 years old and unable to provide informed consent 83 
were excluded from the study.  84 
 85 
Data collected 86 
All participants (cases, recovered group and healthy group) provided written informed consent before 87 
then being asked to complete the Big Five Inventory (BFI) of personality traits, the Generalised Anxiety 88 
Disorders Scale – 7 (GAD-7), the Body Vigilance Scale (BVS), the Dizziness Handicap Inventory (DHI), 89 
the short form of the Vertigo Symptom Scale (VSS), and the Brief Illness Perception Questionnaire 90 
(BIPQ). The BFI consists of 44 questions that assess the five core human personality traits of 91 
neuroticism (tendency toward pessimistic worry), extraversion (outgoing nature), openness (to new 92 
ideas and experiences), agreeableness (affability and warmth), and conscientiousness (diligence and 93 
dutifulness) and provides standardized scores against population norms. Testers respond to the 94 
questions with degrees of agreement or disagreement on a 5-point Likert scale. For each personality 95 
trait, a mean score of higher than 2.5 suggests a tendency towards that trait. The GAD-7 consists of 96 
seven questions that measure the severity of state anxiety. The BVS consists of four questions: the first 97 
three measure sensitivity and attentiveness to bodily sensations in general; the fourth question 98 
measures attentiveness to 15 specific somatic symptoms, including five that are germane to patients 99 
with vestibular disorders (dizziness, nausea, faintness, feelings of unreality, and feelings detached from 100 
one’s self). Testers respond to the questions on an 11 point Likert-like scale ranging from 0 (Not at all 101 
like me) to 10 (Extremely like me). A mean score on higher than 5.0 suggests a tendency towards 102 
strong agreement with the question. The BVS total score is the sum of the answers to questions one to 103 
four. The DHI contains 25 questions that measure the severity of handicap due to dizziness-related 104 
physical and emotional symptoms and interference with functioning.  The short form VSS includes 15 105 
questions,  eight that measure severity of vertiginous symptoms and seven that measure severity of 106 
associated autonomic/anxiety symptoms. The BIPQ consists of 9 questions that assess respondents’ 107 
understanding, emotional response, and sense of control of their illness, as well as concerns about its 108 
causes, consequences, clinical course, and likelihood of treatment response. The DHI, VSS and BIPQ 109 
were administered to the PPPD group only as they were the only ones with active dizziness symptoms 110 
required to make sense of the questionnaires. 111 
 112 
Statistical analysis (performed using SPSS Statistics v26) 113 
Statistical analyses were confined to valid outputs from the questionnaires that tested our hypotheses. 114 
As the DHI, VSS, and GAD-7 have not been validated for item-by-item analyses and the BIPQ has no 115 
total score, analyses were limited to: BFI – scores for the 5 factors; GAD-7 – total score only; BVS – 116 
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individual item scores; DHI – total score only; VSS – total and two subscale scores; BIPQ – individual 117 
items only. 118 
 119 
BFI, GAD-7 & BVS 120 
Each variable was checked for normality (skewness, kurtosis, Shapiro-Wilk’s test), however very few 121 
of the variables were normally distributed. Due to this, and the low sample size, non-parametric tests 122 
were used. Due to having three independent variables (cases, recovered group, healthy group), an 123 
Independent-Samples Kruskal-Wallis test was performed. If a statistically significant result was found, 124 
then a post hoc pairwise comparison was conducted to determine which of the study groups were 125 
statistically different from each other. Statistical significance was determined at p<0.05. Significance 126 
values for pairwise comparisons significance values were adjusted using Bonferroni correction for 127 
multiple tests and were reported as their adjusted values. Effect sizes, η2, were calculated from the 128 
Kruskal-Wallis H-value and were interpreted per usual convention as η2<0.06 (small), 0.06£ η2 <0.14 129 





The clinical care team at the Department of Otolaryngology, Southend University Hospital NHS 135 
Foundation Trust reviewed medical records of current and past patients who were evaluated between 136 
January 2019 and January 2020.  Eighteen patients who had been given a diagnosis of PPPD in 137 
accordance with ICVD criteria (Table 1) during that time period were consecutively asked to take part 138 
in the study. All 18 agreed to participate but only 15 completed and returned the questionnaire (see 139 
below). These 15 patients were included in the PPPD group with the 3 non-responders being  excluded 140 
from the study.  141 
 142 
Controls 143 
Two sex- and age-matched (± 5 years) comparison groups were identified.   The first group  consisted 144 
of patients who had sustained a peripheral vestibular insult but did not develop PPPD (recovered 145 
vestibular patient controls). Participants in this group were all consecutively recruited from the dizziness 146 
and balance clinic, deemed to have recovered from their vestibular insult and not progressed to PPPD. 147 
To be included as a recovered vestibular patient control, patients had to confirm that they had not 148 
experienced any vertigo or dizziness within the last year and were currently asymptomatic. As 149 
labyrinthine function and symptoms in recovered vestibular patients correlate poorly15,16, it was not 150 
deemed necessary to subject controls within this group to further vestibular function testing. 151 
Confirmation of an asymptomatic state was taken as evidence of full compensation from previous 152 
vestibular insult.   153 
 154 
The second group consisted of patients from both the general ENT clinic and other non-ENT clinics 155 
who had never sustained a vestibular insult (non-dizzy patient controls). This group included any patient 156 
who was being followed up for a non-vestibular condition. Patients were asked whether they had ever 157 
experienced vertigo and dysequilibrium in the past or whether they had ever been diagnosed with a 158 
condition that could cause vertigo and only those who had not were asked to participate. The conditions 159 
that these patients were being followed up for included rhinitis (n=2), otitis externa (n=1), tinnitus (n=1), 160 
epistaxis (n=1), tympanic membrane perforation (n=1), single-sided deafness (n=1), chronic back pain 161 
(n=1), knee osteoarthritis (n=1), deep vein thrombosis (n=1), anal polyps (n=1) and COPD (n=1). The 162 
purpose of the non-dizzy comparison group was to control for the state of being ill versus being 163 
healthy.  The psychological measures that were investigated are potentially affected by overall health 164 
status but vary little with respect to specific types of medical illness. 165 
 166 
Demographics 167 
15 PPPD cases (13 (86.7%) females and 2 males, with a mean age was 63.7 years) were matched 168 
with 12 recovered vestibular controls (10 females (83.3%), mean age 63.8 years) and 12 non-dizzy 169 
controls (10 females (83.3%), mean age 62.6 years). The mean duration from diagnosis of PPPD was 170 
5.7 months (range: 0 – 13 months) and the mean duration of PPPD symptoms was 79.5 months (range: 171 
8 – 300 months). In the PPPD group vestibular neuronitis (VN) and benign paroxysmal positional vertigo 172 
(BPPV) were the two most common triggers (both: n=4, 26.7%), followed by Ménière’s disease (n=3, 173 
20%), psychological distress (n=3, 20%) and gentamicin-induced vestibular failure (n=1, 6.7%). Of the 174 
three patients who developed PPPD following psychological distress, all three cited bereavement of a 175 
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spouse (n=2) or parent (n=1) as the trigger of their symptoms. One third of the group were on psychiatric 176 
medication. (See Table 2) The vestibular insults in the recovered vestibular group were BPPV (n=6, 177 
50%), VN (n=4, 33.3%), Ménière’s disease (treated with intratympanic gentamicin therapy; n=1) and 178 
vestibular schwannoma (managed with stereotactic radiotherapy; n=1). 179 
 180 
Big Five Inventory 181 
There was a statistically significant difference between the three study groups in neuroticism (p=0.01; 182 
η2=0.16, large effect), extroversion (p=0.01, η2=0.20, large effect), and conscientiousness (p=0.03; 183 
η2=0.14, large effect),but not openness (p=0.4).  or Agreeableness  trended toward a significant 184 
difference (p=0.09) with a low medium effect; η2=0.08. Pairwise comparison revealed that these results 185 
were largely due to differences between patients with PPPD and non-dizzy controls.  Patients with 186 
PPPD had higher neuroticism than non-dizzy controls (p=0.02; η2=0.43, large effect) whilst non-dizzy 187 
controls were more extroverted (p=0.008; η2=0.49, large effect) and more conscientious (p=0.03; 188 
η2=0.41, , large effect) than patients with PPPD. A pairwise comparison between patients with PPPD 189 
and recovered vestibular controls for neuroticism approached significance (p=0.05).  The effect size, 190 
η2=0.38, was large indicating a clinically meaningful difference that a larger sample would have revealed 191 
as statistically significant ). (See Table 3).  192 
 193 
Generalised Anxiety & Depression – 7 194 
With respect to the overall GAD-7 score, there was a statistically significant difference among groups 195 
(p<0.02;  η2=0.18, large effect).  The mean score for PPPD cases was 10.6; for recovered vestibular 196 
controls was 4.6; for non-dizzy controls was 4.1. Pairwise analysis showed that PPPD cases were 197 
statistically significantly more anxious than non-dizzy controls (p=0.02; η2=0.43, large effect) and 198 
trended toward a difference from recovered vestibular controls (p=0.07); Again, a large effect size, 199 
η2=0.49, suggested a clinically meaningful difference that missed statisitvcal significance due to the 200 
sample size. 201 
 202 
Body Vigilance Scale 203 
There was a statistically significant difference among the study groups in the scores of two subsets of 204 
question 4 of the BVS pertaining to how much attention was paid to specific body sensations: feelings 205 
of dizziness (p<0.0001; η2=0.58, large effect) and unreality (p=0.02; η2=0.15, large effect). In pairwise 206 
comparisons, PPPD cases were found to pay more attention to feelings of dizziness than both control 207 
group (versus recovered vestibular controls: p=0.002, η2=0.53, large effect; versus non-dizzy controls: 208 
p<0.0001, η2=0.72, large effect) and to feelings of unreality  than non-dizzy controls: p=0.02, η2=0.36, 209 
large effect). (See Table 4). 210 
 211 
Brief Illness Perception Questionnaire 212 
Patients with PPPD agreed quite strongly that PPPD affected their life severely and generally felt that 213 
it would last a long time. There was a slightly weaker tendency for patients to indicate feeling like they 214 
had no control over their illness and that the treatment they were on for PPPD was unlikely to help their 215 
symptoms. There were stronger tendencies for patients with PPPD to consider that their symptoms 216 
were severe, concerning, and affecting them emotionally. However they tended to agree that they 217 
understood their illness. When asked to rank the three most likely factors causing their problem, only 218 
one third of the patients listed psychological problems, although the wording could have been 219 
interpreted as the initial trigger rather than the current mechanism of the symptoms. (Table 5).  220 
 221 
DHI & VSS 222 
The mean total DHI score was 29.3/100 (range: 11 – 43, s.d.=9.8), which is at the upper border of the 223 
mild range (0 – 30) on this questionnaire (Whitney, et al. (2004))17. The mean total VSS score was 28.7 224 
(range: 10 – 49; s.d.=10.8).  225 
 226 
Post-hoc analysis 227 
A post-hoc analysis was performed on the data set for BFI, GAD-7 and BVS after removing cases who 228 
developed PPPD following psychological trauma (n=3), leaving a more homogeneous subgroup of 12 229 
patients who developed PPPD following peripheral vestibular illnesses, in total (11 females, 1 male; 230 
mean age 62.8 years; mean months from diagnosis, 6; mean duration of symptoms, 86 months). All 231 
controls (12 recovered vestibular controls and 12 non-dizzy controls) were kept in the data set. The 232 
focus of this sub-analysis was therefore on structural vestibular triggers of PPPD likely to present to the 233 
ENT surgeon. The statistical treatment of this data set was identical to that of the original data set. The 234 
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post-hoc analysis showed a statistically significant result in one question of the BVS only: PPPD patients 235 
were found to pay more attention to feelings of dizziness than both controls (versus recovered vestibular 236 
controls: p=0.007; versus non-dizzy controls: p<0.0001) than both control groups. There were no 237 
statistically significant differences between patients who developed PPPD after a vestibular illness and 238 
either control group with respect to the BFI or GAD-7 questionnaires.  239 
 240 
Discussion 241 
The processes thought to give rise to and then drive PPPD are a combination of those described for its 242 
precursors, namely phobic postural vertigo, space-motion discomfort, visual vertigo and chronic 243 
subjective dizziness2. Anxiety and anxiety-related personality traits, in particular neuroticism, have been 244 
described as possible predisposing factors, making the affected individual prone to a hypervigilant state 245 
of increased introspective self-monitoring that arises from fear of further attacks of vertigo or the 246 
consequences of being dizzy during or following the episode of acute vestibular disease7,10,11,18-25. Yagi, 247 
et al. (2019) have recently developed a PPPD severity questionnaire (the Niigata PPPD Questionnaire) 248 
that reflects the diagnostic criteria of PPPD26.  Even more recently, Powell, et al. (2020) describe PPPD 249 
as a complex neurological condition that includes broad perceptual factors and suggest that some 250 
individuals’ brains are predisposed to generalised cross-modal sensory-overload, giving rise to 251 
vulnerability to severe PPPD should a vestibular insult occur27. What remains to be determined is 252 
whether pre-existing psychological risk factors that can help in predicting who might be at risk of 253 
developing PPPD after an acute vestibular injury, thus allowing for the institution of early treatment3.  254 
 255 
Neuroticism is thought to be one of the key risk factors for the development of PPPD and refers to 256 
relatively stable tendencies to respond with negative emotions to threat, frustration or loss28. Individuals 257 
who score highly on the BFI for neuroticism are more prone to anxiety amongst other negative emotions. 258 
In a functional MRI (fMRI) study by Indovina, et al. (2015) it was shown that reduced activation in human 259 
analogue of the parieto-insular vestibular cortex (PIVC), hippocampus, anterior insula, inferior frontal 260 
gyrus and anterior cingulate cortex, as well as connectivity changes among these regions, may be 261 
linked to long-term vestibular symptoms in patients with CSD29. Also in a fMRI study, Ricelli, et al. (2017) 262 
showed that individual differences in neuroticism were significantly associated with changes in the 263 
activity and functional connectivity patterns within visuo-vestibular and anxiety-related systems during 264 
simulated vertical self-motion30. Similarly, Passamonti, et al. (2018) have shown neuroticism to increase 265 
the activity and connectivity of neural networks that mediate attention to visual motion cues during 266 
vertical motion. They suggest that this mechanism may mediate visual control of balance in neurotic 267 
patients with PPPD31. In our study, PPPD patients were found to be more neurotic than healthy controls. 268 
When compared with recovered controls, the result approached significance only, though the effect size 269 
calculation indicated that this negative finding many have been a Type II error given our small sample 270 
size. Our study also showed PPPD patients to be more introverted and less conscientious than non-271 
dizzy controls, in keeping with previous research findings by Staab, et al. (2014) with respect to chronic 272 
subjective dizziness10.  273 
 274 
Anxiety is a crucial factor in persisting dizziness4. The prevalence of anxiety in PPPD has been the 275 
focus of one of the treatment modalities, namely cognitive behavioural therapy (CBT)32. Toshishige, et 276 
al. (2020) have recently demonstrated in a study of 34 patients with PPPD that the presence of comorbid 277 
anxiety disorders predicted a considerable improvement of DHI score from pre-treatment to 6-month 278 
following CBT33. Our data showed a significant difference in anxiety levels between PPPD cases and 279 
non-dizzy controls. The comparison with recovered vestibular controls did not reach statistical 280 
significance, but again the effect size pointed to a Type II error.  281 
.  282 
 283 
It is interesting that the primary comparisons of all PPPD cases to recovered vestibular controls and 284 
the post-hoc analysis limited to cases of PPPD following vestibular illnesses found no significantly 285 
greater neuroticism or anxiety in those with PPPD. It may be that in a larger cohort, both factors would 286 
be significantly higher in PPPD.  287 
 288 
Alongside anxiety, a high BVS in the setting of acute vestibular disorders has been shown to predict 289 
persistent PPPD-like dizziness far better than measures of structural vestibular deficits4-7,32. In a 290 
prospective longitudinal study, Heinrichs, et al. (2007) assessed fear of bodily sensations and 291 
cognitions related to anxiety at the time of hospital admission and three months later in 43 patients with 292 
an episode of VN or BPPV. They showed that the interaction between fear of bodily sensations within 293 
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the first two weeks after admission and the type of vestibular disorder predicted the extent of dizzy 294 
complaints three months later5. Our study reflects these findings, with attention to a feeling of dizziness 295 
being found to be highly statistically significant in PPPD with respect to the BVS when compared with 296 
both control groups. Our post-hoc analysis also supports this notion by demonstrating the importance 297 
of heightened body vigilance even in a group of patients developing PPPD after vestibular insult. 298 
 299 
There is evidence in other areas of medicine that supports the notion that negative illness perception is 300 
independently linked to all-cause mortality and can strongly influence recovery from illness which can 301 
be slower than in other patients34-36. Illness perception is seen as an important and potentially modifiable 302 
risk factor to target in future disease interventions and intervention has already been shown to reduce 303 
illness anxiety, which has relevance in this study35,37. One interesting finding in our study that despite 304 
PPPD patients being found to be more neurotic and anxious than healthy controls, only one third of 305 
them felt that psychological factors were contributing to their symptoms. This shows similarities to other 306 
functional disorders. In a controlled study of 107 patients with functional weakness, Stone, et al. (2010) 307 
showed that these patients tend to reject psychological factors as potentially causal factors38. They also 308 
demonstrated similar findings, though to a lesser degree, in patients with non-epileptic seizures39. In 309 
PPPD, one potential for this finding may be due to the fact that whilst patients experience their dizziness 310 
most of the time, they may not necessarily attribute their symptoms to anxiety-related factors or consider 311 
anxiety to be a secondary consequence rather than a contributor to their symptoms. Stigmatisation of 312 
mental health issues could also play a role, especially in male patients. Targeted patient education on 313 
the central role anxiety plays in PPPD could help in addressing this misperception and improving illness 314 
perception.   315 
 316 
The results of this study support hypotheses derived from investigations of the predecessors of PPPD 317 
that anxiety-related factors play important roles in promoting the development of the disorder following 318 
conditions that cause vestibular symptoms or disturb balance function, including acute vestibular 319 
disorders. However, these results offer a sharper focus, suggesting specifically that heighted body 320 
vigilance about dizziness and adverse perceptions of illness may distinguish patients likely to develop 321 
PPPD from those more likely to recover from acute illnesses without clinically significant sequelae.The 322 
ultimate goal of this line of research is to develop a risk profile that can be used reliably to identify 323 
patients susceptible to PPPD so that they may receive early and hopefully preventative interventions.  324 
Such a profile is likely to consist of clinical variables present at the time of an acute vestibulopathy (e.g., 325 
anxiety-related personality traits, state anxiety) and ones that emerge in the immediate aftermath of 326 
acute illness before the onset of chronic morbidity (e.g., adverse illness perceptions). 327 
 328 
Study limitations 329 
The participant numbers in this exploratory study were small, so no conclusions may be drawn from the 330 
results. However, the investigation accomplished its stated objective by gathering pilot data from 331 
patients explicitly diagnosed with PPPD to inform the design of more definitive investigations of risk 332 
factors and potential early indicators of the disorder.  333 
 334 
The study was retrospective and carried with it the inherent problems associated with retrospective 335 
studies. Whilst a systematic data collection method was employed, it was collected from patients after 336 
they had developed PPPD and at differing times from the onset, thus representing a heterogeneous 337 
group.  338 
 339 
In our main analysis, PPPD cases were included regardless of their initiating insult, vestibular or 340 
otherwise, despite all members of the recovered group having a history of vestibular insult only. This is 341 
because the ICVD criteria do not sub-categorise PPPD by type of precipitating event. Our post-hoc 342 
analysis suggested that this may have had an effect on our results as the comparisons limited to 343 
patients who developed PPPD following a vestibular disorder identified a narrower range of differences 344 
than the full PPPD cohort compared to recovered controls.  Potential differences risk factors for 345 
development of PPPD following different precipitants merits future study.    346 
 347 
Interestingly, our PPPD group was older and consisted of more women than most other reports of PPPD 348 
and CSD. This may reflect differences in referrals patterns to various clinical centers around the world 349 





The data gathered in this pilot study support the design and conduct of fully powered prospective 353 
investigations of neuroticism, state anxiety, body vigilance and aberrant illness perceptions as risk 354 
factors and contributors to the onset of PPPD that could be formulated into a risk profile to be used for 355 
early detection of the disorder in clinical practice.  356 
 357 
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Figure 1. Potential risk factors for PPPD include, from left to right, anxiety-related personality traits 452 
(primarily neuroticism and introversion) that predate the onset of vestibular symptoms, high levels of 453 
state anxiety and body vigilance that coincide with the onset of vestibular symptoms, and adverse illness 454 
perceptions and dizziness-related handicap that emerge as the course of illness progresses toward 455 
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Table 1. Criteria for the diagnosis of persistent postural-perceptual dizziness (PPPD) as outlined by the 473 
Committee for the Classification of Vestibular Disorders of the Bárány Society (CCBS)2. 474 




One or more symptoms of dizziness, 
unsteadiness, or non-spinning vertigo are present 
on most days for 3 months or more. 
 
1. Symptoms last for prolonged 
(hours long) periods of time 
but may wax and wane in 
severity. 
2. Symptoms need not be 
present continuously 
throughout the entire day. 
 
B Persistent symptoms occur without specific 
provocation, but are exacerbated by three factors: 
1. Upright posture, 
2. Active or passive motion 
without regard to direction or 
position, or 
3. Exposure to moving visual 
stimuli or complex visual 
patterns. 
 
C The disorder is precipitated by conditions that 
cause vertigo, unsteadiness, dizziness, or 
problems with balance including acute, episodic, 
or chronic vestibular syndromes, other 
neurological or medical illnesses, or psychological 
distress. 
1. When the precipitant is an 
acute or episodic condition, 
symptoms settle into the 
pattern of criterion A as the 
precipitant resolves, but they 
may occur intermittently at 
first, and then consolidate into 
a persistent course. 
2. When the precipitant is a 
chronic syndrome, symptoms 
may develop slowly at first and 
worsen gradually. 
 




E Symptoms are not better accounted for by 
another disease or disorder.  
 
 


















Table 2. Demographic data of cases with PPPD. 491 
Cases Age Sex Duration of PPPD 
symptoms(months) 
 



















































300 Ménière’s disease Amitriptyline, 
duloxetine, quetiapine 
11 63 F 
 
132 Psychological distress None 
12 49 F 
 










14 BPPV Sertraline 
15 65 
 
F 8 Vestibular neuronitis None 





























Table 3. Big Five Inventory – Patients with PPPD patients and comparison groups. 516 









Sig. (p) Adj. sig* (p) 
Agreeableness PPPD 
(15) 
3.9 0.13 15.63 
0.09 
RCa-HCb - - 
RC (12) 4.1 0.15 20.2 RC-PPPD - - 
HC (12) 4.4 0.2 27.1 HC-PPPD - - 
Extraversion PPPD 
(15) 
2.7 0.2 13.9 
0.01 
RC-HC 0.15 0.46 
RC (12) 3.4 0.2 20.5 RC-PPPD 0.13 0.4 
HC (12) 3.8 0.1 27.1 HC-PPPD 0.003 0.008 
Conscientiousness PPPD 
(15) 
3.6 0.2 14.2 
0.03 
RC-HC 0.5 1.0 
RC (12) 4.1 0.1 22.0 RC-PPPD 0.08 0.23 
HC (12) 4.2 0.1 25.3 HC-PPPD 0.01 0.03 
Openness PPPD 
(15) 
3.2 0.2 17.3 
0.4 
RC-HC - - 
RC (12) 3.4 0.2 19.9 RC-PPPD - - 
HC (12) 3.6 0.2 23.5 HC-PPPD - - 
Neuroticism PPPD 
(15) 
3.5 0.2 26.8 
0.01 
RC-HC 0.8 1.0 
RC (12) 2.6 0.2 16.4 RC-PPPD 0.02 0.05 
HC (12) 2.5 0.2 15.1 
 
HC-PPPD 0.008 0.02 
*significance values adjusted by Bonferroni correction for multiple tests 517 
aRC – Recovered Controls (recovered vestibular patients) 518 






































Table 4. Body Vigilance Scale (BVS) – Patients with PPPD patients and comparison groups. 555 















Q1. “I am the kind of person who pays 
close attention to internal body 
sensations.” 
PPPD (15) 6.1 0.5 25.9 
0.04 
RC-HC 0.92 1.0 
RCa (12) 3.5 0.9 16.1 RC-PPPD 0.03 0.08 
HCb (12) 3.6 1.0 16.5 HC-PPPD 0.03 0.1 
Q2. “I am very sensitive to changes in 
my internal body sensations.” 
PPPD (15) 5.5 0.7 23.7 
0.3 
RC-HC - - 
RC (12) 3.5 0.9 17.0 RC-PPPD - - 
HC (12) 4.0 1.2 18.4 HC-PPPD - - 
Q3. On average, how much time do 
you spend each day scanning your 
body for sensations? 
PPPD (15) 29.3 7.3 25.5 
0.03 
RC-HC 0.9 1.0 
RC (12) 6.7 3.6 16.8 RC-PPPD 0.03 0.09 
HC (12) 9.2 6.1 16.3 HC-PPPD 0.02 0.07 
Q4. Rate how much attention you pay 
to each of the following sensations 
using this scale: 
 
Q4.1. heart palpitations PPPD (15) 3.3 1.0 21.7 
0.6 
RC-HC - - 
RC (12) 2.9 1.0 20.7 RC-PPPD - - 
HC (12) 2.2 0.9 17.3 HC-PPPD - - 
Q4.2. chest pain/discomfort PPPD (15) 3.5 1.0 23.4 
0.2 
RC-HC - - 
RC (12) 2.4 1.0 19.6 RC-PPPD - - 
HC (12) 1.3 0.7 16.2 HC-PPPD - - 
Q4.3. numbness PPPD (15) 3.5 1.0 22.9 
0.3 
RC-HC - - 
RC (12) 2.3 0.7 20.3 RC-PPPD - - 
HC (12) 1.4 0.8 16.1 HC-PPPD - - 
Q4.4. tingling PPPD (15) 3.5 1.0 23.9 
0.2 
RC-HC - - 
RC (12) 1.7 0.6 17.6 RC-PPPD - - 
HC (12) 1.7 0.8 17.5 HC-PPPD - - 
Q4.5. shortness of breath/smothering PPPD (15) 4.2 1.1 22.2 
0.6 
RC-HC - - 
RC (12) 2.8 1.0 18.3 RC-PPPD - - 
HC (12) 3.0 1.0 19.0 HC-PPPD - - 
Q4.6. faintness PPPD (15) 3.6 1.0 23.5 
0.2 
RC-HC - - 
RC (12) 2.0 0.7 19.7 RC-PPPD - - 
HC (12) 1.4 0.9 16.0 HC-PPPD - - 
Q4.7. vision changes PPPD (15) 4.7 0.8 23.5 
0.3 
RC-HC - - 
RC (12) 2.9 0.8 17.3 RC-PPPD - - 
HC (12) 3.2 1.1 18.3 HC-PPPD - - 
Q4.8. feelings of unreality PPPD (15) 3.1 0.9 25.1 
0.02 
RC-HC 0.4 1.0 
RC (12) 0.8 0.4 18.5 RC-PPPD 0.08 0.2 
HC (12) 0.8 0.8 15.1 HC-PPPD 0.008 0.02 
Q4.9. feeling detached from self PPPD (15) 3.2 0.9 24.6 
0.1 
RC-HC - - 
RC (12) 0.7 0.3 17.3 RC-PPPD - - 
HC (12) 1.7 1.0 17.0 HC-PPPD - - 
Q4.10. dizziness PPPD (15) 8.2 0.5 30.2 
0.0 
RC-HC 0.3 0.8 
RC (12) 2.2 0.9 16.0 RC-PPPD 0.001 0.002 
HC (12) 0.8 0.8 11.2 HC-PPPD 0.0 0.0 
Q4.11. hot flash PPPD (15) 3.7 1.0 22.9 
0.2 
RC-HC - - 
RC (12) 1.3 0.8 15.8 RC-PPPD - - 
HC (12) 3.1 1.0 20.6 HC-PPPD - - 
Q4.12. sweating/clammy hands PPPD (15) 2.7 0.9 21.7 
0.7 
RC-HC - - 
RC (12) 1.5 0.8 18.1 RC-PPPD - - 
HC (12) 2.3 0.9 19.8 HC-PPPD - - 
Q4.13. upset stomach PPPD (15) 4.1 0.9 23.7 
0.2 
RC-HC - - 
RC (12) 1.9 0.8 15.7 RC-PPPD - - 
HC (12) 3.2 1.0 19.6 HC-PPPD - - 
Q4.14. nausea PPPD (15) 3.5 0.8 24.1 
0.1 
RC-HC - - 
RC (12) 2.8 1.0 20.2 RC-PPPD - - 
HC (12) 1.1 0.7 14.6 HC-PPPD - - 
Q4.13. choking/throat closing PPPD (15) 4.0 1.0 24.8 
0.1 
RC-HC - - 
RC (12) 1.8 0.9 17.9 RC-PPPD - - 
HC (12) 1.3 0.8 16.1 HC-PPPD - - 
*significance values adjusted by Bonferroni correction for multiple tests 556 
aRC – Recovered Controls (recovered vestibular patients) 557 








Table 5. Brief Illness Perception Questionnaire (BIPQ) – descriptive statistics for PPPD cases.  564 
 N Mean Std. Deviation 
Q1. How much does your illness affect your life?  (0=no affect at all, 10= 
severely affects my life) 
15 7.4 2.6 
Q2. How long do you think your illness will continue? (0= a very short 
time,; 10= forever) 
14 8.5 2.4 
Q3. How much control do you feel you have over your illness? 
(0=absolutely no control, 10=extreme amount of control) 
15 4.1 4.0 
Q4. How much do you think your treatment can help your illness? 
(0=not at all; 10=extremely helpful) 
14 4.2 3.0 
Q5. How much do you experience symptoms from your illness? (0=no 
symptoms at all; 10=many severe symptoms) 
15 6.3 2.9 
Q6. How concerned are you about your illness? (0= not at all 
concerned; 10= extremely concerned) 
15 6.8 3.3 
Q7. How well do you feel you undertand your illness? (0=don’t 
understand at all, 10=understand very clearly) 
15 6.1 3.2 
 Q8. How much does your illness affect you emotionally? (0=not at all 
affected emotionally; 10=extremely affected emotionally) 
15 6.9 2.9 
 
 Q9. List in rank order the three most important factors that you believe 
caused your illness 
Factor 1 Factor 2 Factor 3 
Case 1 Blocked ears Vertigo - 
Case 2 Heart problem Low BP Head injury 
Case 3 Labyrinthitis - - 
Case 4 Anxiety Poor hearing Anger 
Case 5 Grief Depression Anxiety 
Case 6 - - - 
Case 7 Gentamicin - - 
Case 8 Stress Tiredness Migraines 
Case 9 Viral infections Labyrinthitis Stress 
Case 10 Head trauma Disastrous life - 
Case 11 Mother’s death Father’s cancer Quit smoking 
Case 12 Ménière’s disease - - 
Case 13 Labyrinthitis - - 
Case 14 - - - 
Case 15 Thunderclap 
headaches 
Delay in BPPV 
treatment 
- 
 565 
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